Skip to content
Clinical Trials – home
Ospedale Pediatrico Bambino Gesu
Sponsor

Ospedale Pediatrico Bambino Gesu

Italy Piazza Di Sant'onofrio 4, 00165 Rome, Italy

About the sponsor

Clinical research at Ospedale Pediatrico Bambino Gesu includes CAR T-cell therapy and related immuno-oncology approaches for children and young adults with relapsed/refractory acute lymphoblastic leukemia, B-cell non-Hodgkin lymphoma, neuroblastoma, and GD2-positive tumours.

  • CD19-directed CAR T cells
  • GD2-directed CAR T cells
  • Relapsed/refractory B-cell malignancies
  • Malignant central nervous system tumours

The oncology programme also extends to minimal residual disease assessment and response-focused treatment strategies in paediatric blood cancers and solid tumours.

About Specializations

Ospedale Pediatrico Bambino Gesu runs clinical trials in conditions such as Allogenic stem cell transplantation, Malignant central nervous system neoplasm, Cardiac failure acute, Dilated cardiomyopathy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Ivabradine Hydrochloride
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:BUMETANIDE
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico

Acute HIV infection

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Abacavir
  • Sponsor:Ospedale Pediatrico Bambino Gesu
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Ospedale Pediatrico Bambino Gesu

Bipolar disorder

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Memantine Hydrochloride
  • Sponsor:Ospedale Pediatrico Bambino Gesu

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).